Source: Medicines & Healthcare Products Regulatory Agency (GB) Revision Year: 2011 Publisher: Pierre Fabre Medicament 45, Place Abel Gance, 92100, Boulogne, France
Primalan 5 mg Tablets.
| Pharmaceutical Form |
|---|
|
Round white or almost white tablet, 9mm diameter, flat faced bevel-edged with two score-lines on one face. The score-lines can be used to divide the tablet into equal halves. |
Mequitazine 5 mg.
For a full list of excipients, see section 6.1.
| Active Ingredient | Description | |
|---|---|---|
| Mequitazine |
Mequitazine is a phenothiazine derivative with the actions and uses of antihistamines. Antihistamines diminish or abolish the main actions of histamine in the body by competitive, reversible blaockade of histamine receptor site on tissues; they do not inactivate histamine or prevent its synthesis or release. Antihistamines are used for palliative treatment of allergic reactions. |
| List of Excipients |
|---|
|
Lactose |
Tablet container: 100 tablets.
Bottles (Polyethylene Injection Blow Moulded HDPE): 100 tablets.
Blister: 100 tablets.
Blister: 60 tablets.
Blister: 56 tablets.
Professional Sample Pack: 6 tablets.
Pierre Fabre Medicament 45, Place Abel Gance, 92100, Boulogne, France
PL 05630/0028
21/06/2011
| Drug | Countries | |
|---|---|---|
| PRIMALAN | France, Tunisia |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
